Oncolytics Biotech Inc. (NASDAQ:ONCY) Financings
Financings
| Raise | Date |
|---|---|
| Common shares under equity line of credit (share purchase agreement) Cancelled: raise Buyers: Alumni (obligated to purchase up to US$20 million worth of common stock over a 15-month period); Alumni Capital Use of proceeds: Funding to progress pelareorep's clinical development toward key clinical milestones | Aug 8, 2025 |
| At-the-market programme of common shares Cancelled: Cantor Fitzgerald Dealers: Cantor Fitzgerald | Aug 8, 2025 |